Tarsorrhaphy: clinical experience from a cornea practice
Cosar, C B; Cohen, E J; Rapuano, C J; Maus, M; Penne, R P; Flanagan, J C; Laibson, P R
PURPOSE: To evaluate indications, success rate, and complications of tarsorrhaphy in a cohort of cornea and external disease patients. METHODS: In this study, charts of patients who underwent tarsorrhaphies from January 1, 1995, to September 30, 2000, were retrospectively evaluated. Information reviewed included patient age and sex, indication for tarsorrhaphy, duration of signs and symptoms before tarsorrhaphy, time to epithelial healing after tarsorrhaphy, type of tarsorrhaphy (temporary/permanent), complications, timing of tarsorrhaphy removal, recurrence of signs and symptoms after complete or partial opening of the tarsorrhaphy, number of tarsorrhaphies needed to be replaced or extended, and duration of follow up. RESULTS: Seventy-seven patients were included in this study. Indications for a tarsorrhaphy were persistent epithelial defects or other ocular surface problems associated with neurotrophic ulcers, penetrating keratoplasty (PK), postinfection, exposure keratopathy, surgery other than PK, dry eye syndrome, radiation keratopathy, ocular cicatricial pemphigoid, Stevens-Johnson syndrome, entropion, and application of tissue adhesive. The epithelial defects in 70 (90.9%) of the 77 eyes completely resolved. Overall, the mean duration of signs and symptoms before tarsorrhaphy was 89.8 +/- 27.8 days, and time-to-healing after tarsorrhaphy was 18.0 +/- 2.0 days. The difference between the duration of the signs and symptoms before tarsorrhaphy and time-to-healing after tarsorrhaphy was statistically significant ( p = 0.01). Of the 77 tarsorrhaphies, 24 (31.2%) were temporary and 53 (68.8%) were permanent. Complications after tarsorrhaphy included trichiasis, adhesion between upper and lower lids after tarsorrhaphy lysis, premature opening of the temporary tarsorrhaphy, pyogenic granuloma, and keloid formation of the eyelid. CONCLUSION: Tarsorrhaphy is a very effective and safe procedure in the management of nonhealing epithelial defects and other surface problems, with a 90.9% success rate and only minor complications
PMID: 11685052
ISSN: 0277-3740
CID: 107500
Predictors of recurrent herpes simplex virus keratitis
Barron, BA; Edwards, K; Massare, SJ; McGovern, MS; Williams, D; Capps, SJ; Dragon, DM; Fitzmorris, CT; Graul, EE; Insler, MS; Kaufman, HE; Lacoste, AD; McCaa, CS; Selser, RE; Wagner, NJ; Yokubaitis, JA; Wilhelmus, KR; Todaro, LA; Woodside, SJ; Bowman, CB; Chodosh, J; Gilliam, RM; Goosey, JD; Jones, DB; Kirkland, C; Lehmann, RP; Matoba, AY; Pitts, RE; Scott, PD; Smith, SL; Wolf, TC; Yee, RW; Banuvar, S; Osaki, SY; Cohen, F; Barth, GP; Biswell, R; Cuningham, E; DeMartini, DR; Gritz, D; Hodge, W; Holsclaw, DS; Hwang, DG; Knox, CM; Lietman, T; Margolis, TP; Schwab, IR; Schwartz, L; Sherman, M; Silverstein, B; Vastine, DW; Volpicelli, M; Whitcher, JP; Wilson, S; Wong, IG; Stulting, RD; DuBois, LG; Baldassare, R; Bertram, BA; Chopra, H; Croll, SD; DiIorio, RC; Gussler, JR; Hamilton, SM; John, GR; McCann, JW; Meyer, JC; Mitchell, PG; Palay, DA; Ramirez, RJ; Reed, RE; Serros, RN; Taub, LR; Thompson, KP; Walter, KA; Sugar, J; Rodiek, R; Bouchard, CS; Dennis, R; Feder, RS; Hennessey, MJ; Lubeck, DM; McLeod, SD; Meisler, D; Morimoto, DD; Morimoto, PK; Rubenstein, JB; Tessler, HH; Hyndiuk, RA; Samson, C; Barney, NP; Brightbill, FS; DeCarlo, JD; Fogel, ES; Gainey, SP; Koenig, SB; Kontra, DJ; Krebs, DB; Lewellen, DR; Patalano, SM; Rice, PR; Sanderson, MC; Wienkers, KP; Yeomans, MM; Cohen, EJ; Marshall, SC; Rodriguez, IM; Phipps, P; Altman, AJ; Bailey, RJ; Fung, KL; Hannush, SB; Heffler, KF; Ingraham, HJ; Kesselring, JJ; Kowal, VO; Laibson, PR; Martin, NF; Naidoff, MA; Orlin, SE; Raber, IM; Rapuano, CR; Rubinfeld, RS; Sulewski, ME; Asbell, PA; Justin, N; Azueta, RC; Arroyo, M; Celanges, S; Annunziato, DM; Epstein, S; Barker, BA; Brocks, ER; Choo, NH; Constad, WH; D'Aversa, G; Dunn, MJ; Gorman, BD; Leopold, MR; Newton, MJ; Perez-Arroyo, VE; Schwartz, WJ; Sternberg, G; Udell, IJ; Beck, RW; Moke, PS; Blair, RC; Cole, SR; Gal, R; Gillespie, HA; Kip, K; Long, D; Lester, LA; Mhamdi, ML; Tan, ES; Hauck, WW; Gee, L; Hidayat, JE; Kurinij, N; Asbell, PA; Cohen, EJ; Dawson, CR; Hyndiuk, RA; Jones, DB; Kaufman, HE; Kurinij, N; Moke, PS; Stulting, RD; Sugar, J; Wilhelmus, KR; Bangdiwala, SI; Barlow, WE; Chandler, JW; Lempl, MA; Nesburn, AB; Patrick, DL; Sutphin, JE; Watson, SB; Herpetic Eye Dis Study Grp
Purpose. Determinants of the natural history of recurrent herpes simplex virus (HSV) keratitis have not been consistently established, We assessed how previous HSV eye disease affects the risk of recurrent HSV keratitis and evaluated whether demographic and other variables play any predictive role. Methods. Three hundred forty-six patients in the placebo group of the Herpetic Eye Disease Study's Acyclovir Prevention Trial who had experienced an episode of HSV eye disease in the previous year were followed up for 18 months. Recurrences were categorized according to the type of involvement. Relative rates of recurrence were compared for categories of demographic variables, types and number of previous ocular HSV episodes, previous nonocular HSV infection, and month of the year. Results. Fifty-eight (18%) of the 346 patients developed epithelial keratitis and 59 (18%) developed stromal keratitis during the 18 months of follow-up. Previous epithelial keratitis did not significantly affect the risk of epithelial keratitis (p = 0.84). In contrast, previous stromal keratitis increased the risk of stromal keratitis 10-fold (p < 0.001), and the risk was strongly related to the number of previous episodes (p < 0.001). Age, gender, ethnicity, and nonocular herpes were not significantly associated with recurrences, and no seasonal effects were observed. Conclusion. Among patients who experienced active ocular HSV disease in the previous year, a history of epithelial keratitis was not a risk factor for recurrent epithelial keratitis. In contrast, previous, especially multiple, episodes of stromal keratitis markedly increased the probability of subsequent stromal keratitis. $$:
ISI:000167178900001
ISSN: 0277-3740
CID: 107683